Abstract
A series of 2-amino-4-aryl-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carbonitrile (4a–m) were synthesized via a one-pot three component condensation reaction between 4-hydroxy-2H-chromen-2-one, various aryl aldehydes and malononitrile in the presence of piperidine as a catalyst in ethanol under microwave irradiation conditions, with good to excellent yields. The structure elucidations of all the synthesized compounds were accomplished by spectral data, IR, 1H NMR, 13C NMR, MS, and elemental analyses. The targeted compounds were assessed for their in vitro anticancer activity against mammary gland breast cancer cell line (MCF-7), human colon cancer (HCT-116), and liver cancer (HepG-2) by using sulphorhodamine B assay (SRB) method, while doxorubicin, was utilized as standard reference drug. The cancer cells were treated with the synthesized compounds at differentiable dosages, and cell viability was determined. Compounds 4e, 4f, and 4m exhibited excellent antitumor activity versus all cancer cell lines with IC50 values ranging from 0.2 to 1.7 μM. The cell cycle arrest behavior of compounds 4e, 4f, and 4m was investigated. The results illustrated that the potent cytotoxic compounds 4e, 4f, and 4m induce cell cycle arrest at the G2/M phases and trigger apoptosis in the different tested cancer cells. Finally, the structure activity relationship (SAR) survey highlighted the antitumor activity of the new molecules that was remarkably influenced by the hydrophilicity of certain substituents at certain positions.
Similar content being viewed by others
References
Abbaspour-Gilandeh E, Aghaei-Hashjin M, Yahyazadeh A, Salemi H (2016) CTA)3[SiW12]–Li+–MMT: a novel, efficient and simple nanocatalyst for facile and one-pot access to diverse and densely functionalized 2-amino-4H-chromene derivatives via an eco-friendly multicomponent reaction in water. RSC Adv 6:55444–55462
Abd-El-Aziz AS, Alsaggaf AT, Okasha RM, Ahmed HE, Bissessur R, Abdelghani AA, Afifi TH (2016) Antimicrobial and antitumor screening of fluorescent 5,7-dihydroxy-4-propyl-2H-chromen-2-one derivatives with docking studies. Chem Sel 16:5025–5033
Abd-El-Aziz AS, El-Agrody AM, Bedair AH, Corkery TC, Ata A (2004) Synthesis of hydroxyquinoline derivatives, aminohydroxychromene, aminocoumarin and their antibacterial activities. Heterocycles 63:1793–1812
Abdolmohammadi S, Balalaie S (2007) Novel and efficient catalysts for the one-pot synthesis of 3,4-dihydropyrano[c]chromene derivatives in aqueous media. Tetrahedron Lett 48:3299–3303
Alblewi FF, Okasha RM, Eskandrani AA, Afifi TH, Mohamed HM, Halawa AH, Fouda AM, Al-Dies AM, Mora A, El-Agrody AM (2019a) design and synthesis of novel heterocyclic-based 4H-benzo[h]chromene moieties: targeting antitumor caspase 3/7 activities and cell cycle analysis. Molecules 24:1060
Alblewi FF, Okasha RM, Hritani ZM, Mohamed HM, El-Nassag MAA, Halawa AH, Mora A, Fouda AM, Assiri MA, Al-Dies AM, Afifi TH, El-Agrody AM (2019b) Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene. Bioorg Chem 2019 87:560–571
Anderson DR, Hegde S, Reinhard E, Gomez L, Vernier WF, Lee L, Liu S, Sambandam A, Sinder PA, Masih L (2005) Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg Med Chem Lett 15:1587–1590
Asif M (2017) Various chemical and biological activities of pyridazinone derivatives. Cent Eur J Exp Bio 5:1–19
Baraldi PG, Manfredini S, Simoni D, Tabrizi MA, Balzarini J, De Clercq E (1992) Geiparvarin analogs 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain. J Med Chem 35:1877–1882
Bedair AH, El-Hady NA, Abd El-Latif MS, Fekry AH, El-Agrody AM (2000) 4-Hydroxy- coumarin in heterocyclic synthesis Part III. Synthesis of some new pyrano[2,3-d]pyrimidine, 2-substituted[1,2,4]triazolo[1,5-c]pyrimidine and pyrimido[1,6-b][1,2,4]- triazine derivatives. Il Farm 55:708–714
Bhat MA, Siddiqui N, Khan SA (2008) Synthesis of novel 3-(4-acetyl-5H/methyl-5-substituted phenyl-4,5-dihydro-1,3,4-oxadiazol-2-yl)-2H-chromen-2-ones as potential anticonvulsant agents. Acta Pol Pharm 65:235–239
Bianchi G, Tava A (1987) Synthesis of (2R)-(+)-2,3-Dihydro 2,6-dimethyl-4-pyran-4-one, a Homologue of Pheromones of a Species in the Hepialidae Family. Agric Biol Chem 51:2001–2002
Bonsignore L, Loy G, Secci D, Calignano A (1993) Synthesis and pharmacological activity of 2-oxo-(2H) 1-benzopyran-3-carboxamide derivatives. Eur J Med Chem 28:517–520
Cavalli A, Lizzi F, Bongarzone S, Brun R, Krauth-Siegel RL, Bolognesi ML (2009) Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase. Bioorg Med Chem Lett 19:3031–3035
Cingolani G, Gualtieri F, Pigini M (1969) Notes. Researches in the field of antiviral compounds. Mannich bases 3-hydroxycoumarin J Med Chem 12:531–532
Costa M, Dias TA, Brito A, Proenc F (2016) Biological importance of structurally diversified chromenes. Eur J Med Chem 123:487–507
De Andrade-Neto VF, Goulart MOF, Da Silva Filho JF, Da Silva MJ, Pinto MDCFR, Pinto AV, Zalis MG, Carvalho LH, Krettli AU (2004) Antimalarial activity of phenazines from lapachol, β-lapachone and its derivatives against Plasmodium falciparum in-vitro and Plasmodium berghei in-vivo. Bioorg Med Chem Lett 14:1145–1149
Domling A (2002) Recent advances in isocyanide-based multicomponent chemistry. Curr Opin Chem Biol 6:306–313
Domling A (2006) Recent developments in isocyanide based multicomponent reactions in applied chemistry. Chem Rev 106:17–89
Domling A, Ugi I (2000) Multicomponent reactions with isocyanides. Angew Chem Int Ed 39:3168–3210
El-Agrody AM, Abd El-Latif MS, Fekry AH, Bedair AH (2000) Heteroaromatization with 4-hydroxycoumarin part I: synthesis of some new pyranocoumarin and coumarinopyranopyrimidine derivatives. J Chem Res (S):26–27
Emmadi NR, Atmakur K, Chityal GK, Pombala S, Nanubolu JB (2012) Synthesis and cytotoxicity evaluation of highly functionalized pyranochromenes and pyranopyrans. Bioorg Med Chem Lett 22:7261–7264
Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1:2207–16
Fouda AM (2016) Synthesis of several 4H-chromene derivatives of expected antitumor activity. Med Chem Res 25:1229–1238
Fouda AM (2017) Halogenated 2-amino-4H-pyrano[3,2-h]quinoline-3-carbonitriles as antitumor agents and structure-activity relationships of the 4- and 6-, 9-positions. Med Chem Res 26:302–313
Gong K, Wang HL, Luo J, Liu ZL (2009) One-pot synthesis of polyfunctionalized pyrans catalyzed by basic ionic liquid in aqueous media. J Heterocycl Chem 46:1145–1150
Hazeri N, Maghsoodlou MT, Mir F, Kangani M, Saravani H, Molashahi E (2014) An efficient one-pot three-component synthesis of tetrahydrobenzo[b]pyran and 3,4-dihydropyrano[c]chromene derivatives using starch solution as catalyst. Chin J Catal 35:391–395
Heravi MM, Jani BA, Derikvand F, Bamoharram FF, Oskooie HA (2008) Three component, one-pot synthesis of dihydropyrano[3,2-c]chromene derivatives in the presence of H6P2W18O62· 18H2O as a green and recyclable catalyst. Catal Commun 10:272–275
Heravi MM, Sadjadi S, Haj NM, Oskooie HA, Bamoharram FF (2009) Role of various heteropolyacids in the reaction of 4-hydroxycoumarin, aldehydes and ethylcyanoacetate. Catal Commun 10:1643–1646
Heravi MM, Zakeri M, Mohammadi N (2011) Morpholine catalyzed one-pot multicomponent synthesis of compounds containing chromene core in water. Chin J Chem 29:1163–1166
Hofmeister V, Vetter C, Schrama D, Brocker EB, Becker JC (2006) Tumor stroma-associated antigens for anti-cancer immunotherapy. Cancer Immunol Immunother 55:481–494
Kakanejadifard A, Azarbani F, Khosravani N, Notash B (2016) Synthesis, structural characterization, X–ray, solvatochromism and biological properties of 7-hydroxy-2-(2-hydroxy-5-(phenyldiazenyl)benzylidene)amino)-4-phenyl-4H-chromene-3-carbonitrile. J Mol Liq 221:211–215
Karimi AR, Sedaghatpour F (2010) Novel mono- and bis (spiro-2-amino-4H-pyrans): alum-catalyzed reaction of 4-hydroxycoumarin and malononitrile with isatins, quinones, or ninhydrin. Synthesis 10:1731–1735
Kashman Y, Gustafson KR, Fuller RW, Cardellina JH, Mcmahon JB, Currens MJ, Buckheit RW, Hughes SH, Cragg GM, Boyd MR (1992) HIV inhibitory natural products.Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem 35:2735–2743
Khurana JM, Kumar S (2009) Tetrabutylammonium bromide (TBAB): a neutral and efficient catalyst for the synthesis of biscoumarin and 3,4-dihydropyrano[c]chromene derivatives in water and solvent-free conditions. Tetrahedron Lett 50:4125–4127
Khurana JM, Nand B, Saluja P (2010) DBU: a highly efficient catalyst for one-pot synthesis of substituted 3,4-dihydropyrano[3,2-c]chromenes, dihydropyrano[4,3-b]pyranes, 2-amino-4H-benzo[h]chromenes and 2-amino-4H benzo[g]chromenes in aqueous medium. Tetrahedron 66:5637–5641
Kidwai M, Saxena S (2006) convenient preparation of pyrano benzopyranes in aqueous media. Synth Commun 36:2737–2742
Kidwai M, Venkataramanan R, Mohan R, Sapra P (2002) Cancer chemotherapy and heterocyclic compounds. Curr Medicinal Chem 9:12091228
Kinghorn AD, Farnsworth NR, Soejarto DD, Cordell GA, Swanson SM, Pezzuto JM, Wani MC, Wall ME, Oberlies NH, Kroll DJ, Kramer RA, Rose WC, Vite GD, Fairchild CR, Peterson RW, Wild R (2003) Novel strategies for the discovery of plant-derived anticancer agents. Pharm Biol 41:53–67
Kircheis R, Wightman L, Kursa M, Ostermann E, Wagner E (2002) Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment. Gene Ther 9:731–735
Kiyani M, Tazari M (2017) Aqua one-pot, three-component synthesis of dihydropyrano[3,2-c]chromenes and aminobenzochromenes catalyzed by sodium malonate. Res Chem Intermed 43:6639–6650
Konkoy CS, Fick DB, Cai SX, Lan NC, Keana JFW (2000) PCT Int Appl WO 0075123. Chem Abstr 134:29313
Li Z-p, Lib J, Qu D, Hou Z, Yang X-h, Zhang Z-d, Wang Y-k, Luo X-x, Li M-k (2014) Synthesis and pharmacological evaluations of 4-hydroxycoumarin derivatives as a new class of anti-Staphylococcus aureus agents. J Pharm Pharmacol 67:573–582
Mehrabi H, Abusaidi H (2010) Synthesis of biscoumarin and 3,4-dihydropyrano[c]chromene derivatives catalysed by sodium dodecyl sulfate (SDS) in neat water. J Iran Chem Soc 7:890–894
Mohr SJ, Chirigios MA, Fuhrman FS, Pryor JW (1975) Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor. Cancer Res 35:3750–3754
Moon DO, Choi YH, Kim ND, Park YM, Kim GY (2007) Anti-inflammatory effects of beta-lapachone in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol 7:506–514
Nikaljea AP, Bahetia K (2017) Computer based drug design of various heterocyclic compounds having anticancer activity: a brief review. J Bioinform Genomics, Proteom 2:1014–1026
Orru RVA, de Greef M (2003) Recent advances in solution phase multicomponent methodology for the synthesis of heterocyclic compounds. Synthesis 10:1471–1499
Patil AD, Freyer AJ, Eggleston DS, Haltiwanger RC, Bean MF, Taylor PB, Caranfa MJ, Breen AL, Bartus HR (1993) The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. J Med Chem 36:4131–4138
Paul S, Bhattacharyya P, Das AR (2011) One-pot synthesis of dihydropyrano[2,3-c]chromenes via a three component coupling of aromatic aldehydes, malononitrile, and 3-hydroxycoumarin catalyzed by nano-structured ZnO in water: a green protocol. Tetrahedron Lett 52:4636–4641
Perrella FW, Chen SF, Behrens DL, Kaltenbach III RF, Seitz SP (1994) Phospholipase C Inhibitors: a new class of agents. J Med Chem 37:2232–2237
Rahimi R, Mahdavi M, Pejman S, Zare P, Balalaei S (2015) Inhibition of cell proliferation and induction of apoptosis in K562 human leukemia cells by the derivative (3-NpC) from dihydro-pyranochromenes family. Acta Biochim Pol 62:83–88
Ramalhoa SD, Bernadesc A, Demetriusa G, Noda-Perez C, Vieirab PC, dos Santosb CY, da Silvab JA, de Moraesd MO, Mousinhod KC (2013) Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation. Chem Biodivers 10:1999–2006
Rueping M, Sugiono E, Merino E (2008) Asymmetric organocatalysis: an efficient enantioselective access to benzopyranes and chromenes. Chem Eur J 14:6329–6332
Schwartz GK, Shah MA (2005) Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23:9408–9421
Seifi M, Sheibani H (2008) High surface area MgO as a highly effective heterogeneous base catalyst for three-component synthesis of tetrahydrobenzopyran and 3,4-dihydropyrano [c]chromene derivatives in aqueous media. Catal Lett 126:275–279
Shaabani A, Samadi S, Badri Z, Rahmati A (2005) Ionic liquid promoted efficient and rapid one-pot synthesis of pyran annulated heterocyclic systems. Catal Lett 104:39–43
Shaker RMR (1996) Synthesis and reactions of some new 4H-pyrano [3,2-c] benzopyran-5-one derivatives and their potential biological activities. Pharmazie 51:148–151
Shi DQ, Wu N, Zhuang QY (2008) Synthesis of 2-amino-4-aryl-5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives catalysed by KF-montmorillonite. J Chem Res 54:542–545
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107–1112
Smith PW, Sollis SL, Howes PD, Cherry PC, Starkey ID, Cobley KN, Weston H, Scicinski J, Merritt A, Whittington A, Wyatt P, Taylor N, Green D, Bethell R, Madar S, Fenton RJ, Morley PJ, Pateman T, Beresford A (1998) Dihydropyrancarboxamides Related to Zanamivir: A New Series of Inhibitors of Influenza Virus Sialidases. 1. Discovery, Synthesis, Biological Activity, and Structure−Activity Relationships of 4-Guanidino- and 4-Amino-4H-pyran-6-carboxamides. J Med Chem 41:787–797
Tan JN, Lia M, Gu Y (2010) Multicomponent reactions of 1,3-disubstituted 5-pyrazolones and formaldehyde in environmentally benign solvent systems and their variations with more fundamental substrates. Green Chem 12:908–914
Terrett NK, Gardner M, Gordon DW, Kobylecki RJ, Steele J (1995) Combinatorial synthesis–the design of compound libraries and their application to drug discovery. Tetrahedron 51:8135–8173
Ugi I (1997) Multicomponent reactions (MCR): perspectives of multicomponent reactions and their libraries. Adv Synth Catal 339:499–516
Weber L (2002) Multi-component reactions and evolutionary chemistry. Drug Discov Today 7:143–147
Welsch ME, Snyder SA, Stockwel BR (2010) Privileged scaffolds for library design and drug discovery. Curr Opin Chem Biol 14:347–361
Williams GH, Stoeber K (2012) The cell cycle and cancer. J Pathol 226:352–364
Yang CM, Jeganmohan M, Parthasarathy K, Cheng CH (2010) Nickel catalyzed three-component coupling of alkynes with enones and alkenyl boronic acids: a novel route to substituted 1,3-dienes. Org Lett 12:3610–3613
Acknowledgements
The authors extend their appreciation to the Deanship of Science Research at King Khalid University for funding this work through General Research Project under Grant Number (R.G.P.1/111/40). In addition, the authors deeply thank the Regional Center for Mycology & Biotechnology (RCMP), Al-Azhar University, Cairo, Egypt, for carrying out the antitumor study, elemental analyses and also, for Mr. Ali Y. A. Alshahrani for drawing the 1H NMR and 13C NMR spectra.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
El-Agrody, A.M., Fouda, A.M., Assiri, M.A. et al. In vitro anticancer activity of pyrano[3, 2-c]chromene derivatives with both cell cycle arrest and apoptosis induction. Med Chem Res 29, 617–629 (2020). https://doi.org/10.1007/s00044-019-02494-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-019-02494-3